Shapu Aisi stocks have been suspended for continuous trading and illegal advertising and are required to conduct self-inspection

　　Shapu Aisi, stock trading has stopped and illegal advertisements have been asked to conduct self-inspection!

　　Shapu Aisi stock, continuous suspension

　　On December 7, Zhejiang Shapu Aisi issued a "Reminder Announcement on Continuous Suspension of the Company's Stocks". The announcement shows that Zhejiang Shapu Aisi learned from the General Administration's website on the evening of December 6, 2017 that the "Notice of the General Administration on Matters Related to Shapu Aisi Eye Drops" and the company urgently applied for the suspension of trading on December 7, 2017. On the afternoon of December 7, 2017, the Zhejiang Provincial Food and Drug Administration received the "Notice of Forwarding the State Food and Drug Administration on Matters Related to Shapu Aisi Eye Drops". Due to the need for further verification of related matters, relevant work and specific measures are to be implemented, the company applied to continue to suspend trading from December 8, 2017.

　　Stopping a trading market is like stopping a worker in a pharmaceutical factory

　　Suspension, some professionals explained: The literal meaning is very simple, which means temporarily stopping trading, but suspension of trading is divided into many situations, such as: normal suspension of trading due to release of major information or accounting statements, etc. In this case, the suspension time is generally short, from a few hours to a day, and generally has little impact on the stock price; there is another situation where the suspension is suspended due to poor management or violations, such suspension is abnormal, and the suspension time is generally long, which has a great impact on the risk of the stock price. To make an image metaphor, a one-day suspension of trading is like a pharmaceutical factory shutting down one day, which has a great impact on listed companies.

　　Zhejiang Food and Drug Administration requires correction of illegal advertising

　　In the announcement, Zhejiang Shapu Aisi said that on December 7, Zhejiang Food and Drug Administration announced it on its official website. On the one hand, the Zhejiang Food and Drug Administration notified the company to launch clinical effectiveness trials as soon as possible, and reported the evaluation results to the Drug Review Center of the State Food and Drug Administration within three years. At the same time, Shapu Aisi was asked to conduct an advertising self-inspection immediately. For advertisements, publicity, logos, slogans, etc. published on various domestic media regarding benzodalysine eye drops, strictly check the textual expressions stipulated in the indications of the drug instructions and the relevant provisions of advertising regulations. If the regulations do not meet the regulations, it will be corrected immediately and reported to the local market supervision bureau. And strictly implement drug GMP and GSP to ensure the quality and safety of the drug life cycle.

　　Substantial change, just beginning

　　In addition, in the notice from the Zhejiang Food and Drug Administration, the documents issued by the General Administration were also posted together. In the notice of the General Administration, there is a conspicuous word "express". From the "Dingxiang Doctor"'s post on December 2, to the connection between the General Administration and the Zhejiang Bureau, to the series of reactions from Shapu Aisi, this matter may no longer be popular, but the substantial advancement has just begun.

Thank you for your attention and support to Laogao E-commerce Club . Please indicate the source of the reprinting website www.shxuanming.net

 Click to register to apply to join the well-known e-commerce network - Laogao E-commerce Club. Any merchants from all over the country, Tmall merchants, Taobao Crown Store, Jinguan Store, and other e-commerce platform merchants can apply to join!